NLRP3 and uveitis: Accumulating evidence implies that inflammasome activation contributes to tissue damage in various ocular diseases, including glaucoma, diabetic retinopathy and AMD [20], and aberrant activation of the NLRP3 inflammasome was demonstrated in uveitis patients and murine models of uveitis [44].